A summary of recent pediculosis product news.
Lanes Health, a UK company with a broad prospectus of health products, has recently negotiated the purchase of the rights to Derbac M, the malathion-based pediculosis treatment, from Reckitt Benckiser.
ParaPRO recently announced that the US Food and Drug Administration has reduced the age-indication for its Natroba pediculosis treatment down to six months.
Natroba received FDA approval in 2011 for treatment in children four years of age and older.
Numark have recently released their Numark Head Lice Treatment 1%, a permethrin-based pediculosis treatment.